Founded
31 Dec 2006
Address
Peer39 Inc
2 West 45th Street
17th Floor Suite 1700
New York, NY 10036
United States
Peer39 Inc
36 West 25th Street
2nd Floor
New York, NY 10010
United States
Peer39 Inc
2 West 45th Street
17th Floor, Suite 1700
New York, NY 10036
United States
Peer39 Inc
2 West 45th Street
17th Floor, Suite 1700
New York, NY 10036
United States
Peer39 Inc
2 West 45th Street
17th Floor, Suite 1700
New York, NY 10036
United States
Website
Industry
VCID: 522758
Profile
Corporate information
Registration country
Official identities
Registration country
Official identities
Investment activity status
Active investor
Company type
Provides semantic advertising solutions.Funding
Funding rounds
(1 May 2011)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | United States | ||
Evergreen Venture Partners | Israel |
(1 May 2009)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | United States | ||
Dawntreader Ventures | United States | |||
Evergreen Venture Partners | Israel | |||
JP Morgan & Co | United States | |||
SVB Financial Group | United States |
(1 Sep 2007)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | United States | ||
Dawntreader Ventures | United States | |||
JP Morgan & Co | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies |
+1 (203) 855-0400 |
N/A Series B Series C |
|
Daniel Ciporin |
Seed | ||
Dawntreader Ventures |
+1 (646) 452-6100 |
Series A Series B Series C |
|
Evergreen Venture Partners |
+972 (3) 710-8282 |
N/A Series C |
|
JP Morgan & Co |
Series B Series C |
||
SVB Financial Group |
Series C |